Sequencing Newsletter—Issue 25
2018, Issue 25
Welcome to the first issue of Sequencing Newsletter for 2018.
In each issue, we will cover different research areas, providing you with the tools you need to obtain meaningful results in the most efficient way possible.
So why Sequencing Newsletter, you ask? It’s to address an assumption that you are aware of everything we have to offer. With over 100,000 products available, of course you aren’t. From local events, to our educational videos and resources for your research and our top products, we hope to help you to find the answers you are looking for.
From the field: Asking the question that needs to be answered
SeqStudio Sanger sequencing aids translational research
Dr. Luca Quagliata, Sr. Director at the University Hospital of Basel, discusses how Sanger sequencing with the Applied Biosystems SeqStudio Genetic Analyzer performs a valuable and readily identifiable role in translational research. "For example,” he says, “what is the question that needs to be answered? How big is the sample itself?” According to Quagliata, if researchers are only interested in a small number of genes, or if the starting sample size is small, then Sanger is the best method.
Meet the new Ion GeneStudio S5 systems
Find out how a single instrument can easily scale to accommodate multiple applications, throughputs, and data outputs.
Speed and flexibility improve lab competitiveness
We recently caught up with Morten Dunø at his lab in Copenhagen, Denmark, who shared a few thoughts about exome trios, and next-gen sequencing.
News you can use: There is always time to learn
Video: Learn how Oncomine research informatics can help guide your cancer research decisions
Webinar: Next-generation sequencing in NSCLC—it works, it makes sense… it’s time!
Tuesday 6 March 2018 at 17:00 (CET)
New 3-part webinar series: New frontiers in liquid biopsy research
This monthly webinar series will kick off in March and showcase the opportunities and challenges of implementing innovative liquid biopsy technologies for cancer research.
March 27 @ 10 am EST
Speakers: Dr. Bea Bellosillo, Dr. Kelli Bramlett
Adding CNVs and fusions to a lung cfDNA assay: impact on oncology clinical research
April 26 @ 11 am EST
Speaker: Dr. Luca Quagliata
Evaluation of a pan-cancer cell-free assay to meet unmet research needs
May 22 @ 11 am EST
Speaker: Dr. Liya Xu
From qualitative to quantitative: experiences with a cfDNA assay in metastatic breast cancer